Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases

World Journal of Gastroenterology

Volumn 19, Issue 35, 2013, Pages 5775-5786

  Abu Wasel, Bassam ^a   Walsh, Caolan ^a   Keough, Valerie ^a   Molinari, Michele ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Classification; Epidemiolgy; Genetic; Hepatic; Polycystic liver disease; Therapy

Indexed keywords

ANGIOPEPTIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PLACEBO; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; VASCULOTROPIN;

APOPTOSIS; ARTIFICIAL EMBOLISM; ASCITES; BILE LEAKAGE; BLEEDING; CAVA VEIN OBSTRUCTION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; FENESTRATION; HUMAN; INCIDENCE; INFECTION; INTERVENTIONAL RADIOLOGY; LIVER CYST; LIVER POLYCYSTIC DISEASE; LIVER RESECTION; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SCLEROTHERAPY; SEPSIS;

CLASSIFICATION; EPIDEMIOLGY; GENETIC; HEPATIC; POLYCYSTIC LIVER DISEASE; THERAPY;

CYSTS; LIVER DISEASES; DIAGNOSTIC IMAGING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84885656878     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i35.5775     Document Type: Review

References (124)

1. Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int 2008; 28: 264-270 [PMID: 17927714 DOI: 10.1111/ j.1478-3231.2007.01595.x]
2. Bristowe F. Cystic disease of the liver associated with similar disease of the kidneys. Trans Pathol Soc Lond 1856; 7: 229-234
3. Moschcowitz E. Non-parasitic cysts (congenital) of the liver, with a study of aberrant bile ducts. Am J Med Sci 1906; 131: 674-699 [DOI: 10.1097/00000441-190604000-00011]
4. Feldman M. Polycystic disease of the liver. Am J Gastroenterol 1958; 29: 83-86 [PMID: 13497992]
5. Tahvanainen P, Tahvanainen E, Reijonen H, Halme L, Kääriäinen H, Höckerstedt K. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol 2003; 38: 39-43 [PMID: 12480558 DOI: 10.1016/S0168-8278(02)00348-3]
6. Torres VE. Treatment of polycystic liver disease: one size does not fit all. Am J Kidney Dis 2007; 49: 725-728 [PMID: 17533013 DOI: 10.1053/j.ajkd.2007.04.009]
7. Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 2005; 100: 2569-2582 [PMID: 16279915 DOI: 10.1111/j.1572-0241.2005.00263.x]
8. Vauthey JN, Maddern GJ, Blumgart LH. Adult polycystic disease of the liver. Br J Surg 1991; 78: 524-527 [PMID: 2059797 DOI: 10.1002/bjs.1800780505]
9. Grünfeld JP, Albouze G, Jungers P, Landais P, Dana A, Droz D, Moynot A, Lafforgue B, Boursztyn E, Franco D. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp 1985; 14: 1-20 [PMID: 2983516]
10. Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-2230 [PMID: 21105111 DOI: 10.1002/hep.24036]
11. Temmerman F, Missiaen L, Bammens B, Laleman W, Cassiman D, Verslype C, van Pelt J, Nevens F. Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther 2011; 34: 702-713 [PMID: 21790682 DOI: 10.1111/j.1365-2036.2011.04783.x]
12. Qian Q. Isolated polycystic liver disease. Adv Chronic Kidney Dis 2010; 17: 181-189 [PMID: 20219621 DOI: 10.1053/ j.ackd.2009.12.005]
13. D'Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994; 14: 215-228 [PMID: 7939783 DOI: 10.1055/ s-2007-1007313]
14. Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, Li A, Cai Y, Kamath PS, King BF, Azurmendi PJ, Tahvanainen P, Kääriäinen H, Höckerstedt K, Devuyst O, Pirson Y, Martin RS, Lifton RP, Tahvanainen E, Torres VE, Somlo S. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004; 36: 575-577 [PMID: 15133510 DOI: 10.1038/ng1357]
15. Van Keimpema L, De Koning DB, Van Hoek B, Van Den Berg AP, Van Oijen MG, De Man RA, Nevens F, Drenth JP. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int 2011; 31: 92-98 [PMID: 20408955 DOI: 10.1111/ j.1478-3231.2010.02247.x]
16. Desmet VJ. Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998; 73: 80-89 [PMID: 9443684 DOI: 10.1016/ S0025-6196(11)63624-0]
17. Ramos A, Torres VE, Holley KE, Offord KP, Rakela J, Ludwig J. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114: 180-184 [PMID: 2302034]
18. Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J, Shub C, Davila S, Somlo S, Torres VE. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003; 37: 164-171 [PMID: 12500201 DOI: 10.1053/jhep.2003.50006]
19. Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 2004; 127: 1565-1577 [PMID: 15521023 DOI: 10.1053/ j.gastro.2004.08.006]
20. Everson GT, Emmett M, Brown WR, Redmond P, Thickman D. Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin. Hepatology 1990; 11: 557-565 [PMID: 1970324 DOI: 10.1002/hep.1840110406]
21. Perrone RD, Grubman SA, Rogers LC, Lee DW, Moy E, Murray SL, Torres VE, Jefferson DM. Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium. Am J Physiol 1995; 269: G335-G345 [PMID: 7573443]
22. Nichols MT, Gidey E, Matzakos T, Dahl R, Stiegmann G, Shah RJ, Grantham JJ, Fitz JG, Doctor RB. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004; 40: 836-846 [PMID: 15382115]
23. Wheatley DN. Primary cilia in normal and pathological tissues. Pathobiology 1995; 63: 222-238 [PMID: 8866794 DOI: 10.1159/000163955]
24. Ong AC, Wheatley DN. Polycystic kidney disease--the ciliary connection. Lancet 2003; 361: 774-776 [PMID: 12620752 DOI: 10.1016/S0140-6736(03)12662-1]
25. Davenport JR, Yoder BK. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol 2005; 289: F1159-F1169 [PMID: 16275743 DOI: 10.1152/ajprenal.00118.2005]
26. Harris RA, Gray DW, Britton BJ, Toogood GJ, Morris PJ. Hepatic cystic disease in an adult polycystic kidney disease transplant population. Aust N Z J Surg 1996; 66: 166-168 [PMID: 8639135 DOI: 10.1111/j.1445-2197.1996.tb01148.x]
27. Sherstha R, McKinley C, Russ P, Scherzinger A, Bronner T, Showalter R, Everson GT. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997; 26: 1282-1286 [PMID: 9362373]
28. van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009; 137: 1661-8. e1-2 [PMID: 19646443]
29. Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010; 21: 1052-1061 [PMID: 20431041 DOI: 10.1681/ASN.2009121291]
30. Caroli A, Antiga L, Cafaro M, Fasolini G, Remuzzi A, Remuzzi G, Ruggenenti P. Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. Clin J Am Soc Nephrol 2010; 5: 783-789 [PMID: 20185596 DOI: 10.2215/CJN.05380709]
31. Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol 2006; 12: 3537-3545 [PMID: 16773710]
32. Everson GT, Scherzinger A, Berger-Leff N, Reichen J, Lezotte D, Manco-Johnson M, Gabow P. Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts. Hepatology 1988; 8: 1627-1634 [PMID: 3192176 DOI: 10.1002/hep.1840080626]
33. Dmitrewski J, Olliff S, Buckels JA. Obstructive jaundice associated with polycystic liver disease. HPB Surg 1996; 10: 117-120 [PMID: 9184868 DOI: 10.1155/1996/83547]
34. Abascal J, Moya M, Martin F. Infection of hepatic cysts in polycystic disease. World J Surg 1984; 8: 424-425 [PMID: 6380124 DOI: 10.1007/BF01655097]
35. van Erpecum KJ, Janssens AR, Terpstra JL, Tjon A Tham RT. Highly symptomatic adult polycystic disease of the liver. A report of fifteen cases. J Hepatol 1987; 5: 109-117 [PMID: 3655307 DOI: 10.1016/S0168-8278(87)80068-5]
36. Que F, Nagorney DM, Gross JB, Torres VE. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 1995; 108: 487-494 [PMID: 7835591 DOI: 10.1016/0016-5085(95)90078-0]
37. Kabbej M, Sauvanet A, Chauveau D, Farges O, Belghiti J. Laparoscopic fenestration in polycystic liver disease. Br J Surg 1996; 83: 1697-1701 [PMID: 9038542 DOI: 10.1002/ bjs.1800831211]
38. Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, Collard A, Geubel A, Pringot J, Kestens PJ. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg 1997; 225: 286-294 [PMID: 9060585 DOI: 10.1097/00000658-199703000-0 0008]
39. Waanders E, van Keimpema L, Brouwer JT, van Oijen MG, Aerts R, Sweep FC, Nevens F, Drenth JP. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009; 29: 1389-1395 [PMID: 19515221 DOI: 10.1111/ j.1478-3231.2009.02055.x]
40. Deschênes M, Michel RP, Alpert E, Barkun JS, Metrakos P, Tchervenkov J. Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates. Transplantation 2001; 72: 1519-1522 [PMID: 11707739 DOI: 10.1097/000 07890-200111150-00008]
41. Iwase K, Takenaka H, Oshima S, Yagura A, Nishimura Y, Yoshidome K, Tanaka T. Determination of tumor marker levels in cystic fluid of benign liver cysts. Dig Dis Sci 1992; 37: 1648-1654 [PMID: 1385056 DOI: 10.1007/BF01299853]
42. McCormick SE, Sjogren MH, Goodman ZD. A 22-year-old man with a liver mass and markedly elevated serum alpha fetoprotein. Semin Liver Dis 1994; 14: 395-403 [PMID: 7531871 DOI: 10.1055/s-2007-1007330]
43. Schievink WI, Spetzler RF. Screening for intracranial aneurysms in patients with isolated polycystic liver disease. J Neurosurg 1998; 89: 719-721 [PMID: 9817407 DOI: 10.3171/ jns.1998.89.5.0719]
44. Ong AC. Screening for intracranial aneurysms in ADPKD. BMJ 2009; 339: b3763 [PMID: 19770180 DOI: 10.1136/bmj. b3763]
45. Lumiaho A, Ikäheimo R, Miettinen R, Niemitukia L, Laitinen T, Rantala A, Lampainen E, Laakso M, Hartikainen J. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 2001; 38: 1208-1216 [PMID: 11728952 DOI: 10.1053/ ajkd.2001.29216]
46. Xu HW, Yu SQ, Mei CL, Li MH. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011; 42: 204-206 [PMID: 21164130 DOI: 10.1161/STROKEAHA.110.578740]
47. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-228 [PMID: 19322187 DOI: 10.1038/ nrneph.2009.13]
48. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-5059 [PMID: 17876869]
49. Torra R, Nicolau C, Badenas C, Navarro S, Pérez L, Estivill X, Darnell A. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 1997; 47: 19-22 [PMID: 9021236]
50. Blyth H, Ockenden BG. Polycystic disease of kidney and liver presenting in childhood. J Med Genet 1971; 8: 257-284 [PMID: 5097134 DOI: 10.1136/jmg.8.3.257]
51. Milutinovic J, Schabel SI, Ainsworth SK. Autosomal dominant polycystic kidney disease with liver and pancreatic involvement in early childhood. Am J Kidney Dis 1989; 13: 340-344 [PMID: 2705452]
52. Levine E, Cook LT, Grantham JJ. Liver cysts in autosomaldominant polycystic kidney disease: clinical and computed tomographic study. AJR Am J Roentgenol 1985; 145: 229-233 [PMID: 3875218 DOI: 10.2214/ajr.145.2.229]
53. Nicolau C, Torra R, Bianchi L, Vilana R, Gilabert R, Darnell A, Brú C. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound 2000; 28: 277-282 [PMID: 10867665]
54. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP. Magnetic resonance imaging evaluation of hepatic cysts in early autosomaldominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 2006; 1: 64-69 [PMID: 17699192 DOI: 10.2215/CJN.00080605]
55. Vachha B, Sun MR, Siewert B, Eisenberg RL. Cystic lesions of the liver. AJR Am J Roentgenol 2011; 196: W355-W366 [PMID: 21427297 DOI: 10.2214/AJR.10.5292]
56. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827 [PMID: 7908078 DOI: 10.1016/S0140-6736(94)92026-5]
57. Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003; 58: 626-629 [PMID: 12887956 DOI: 10.1016/ S0009-9260(03)00165-X]
58. Chauveau D, Fakhouri F, Grünfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol 2000; 11: 1767-1775 [PMID: 10966503]
59. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301 [PMID: 17434405 DOI: 10.1016/S0140-6736(07)60601-1]
60. Migali G, Annet L, Lonneux M, Devuyst O. Renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2008; 23: 404-405 [PMID: 17913735 DOI: 10.1093/ndt/gfm665]
61. Lahiri SA, Halff GA, Speeg KV, Esterl RM. In-111 WBC scan localizes infected hepatic cysts and confirms their complete resection in adult polycystic kidney disease. Clin Nucl Med 1998; 23: 33-34 [PMID: 9442963 DOI: 10.1097/00003072-19980 1000-00010]
62. Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking AP, Alberini JL. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med 2008; 22: 529-531 [PMID: 18670861 DOI: 10.1007/s12149-008-0150-3]
63. Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission to-mography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003; 41: E18-E21 [PMID: 12776306 DOI: 10.1016/S0272-6386(03)00368-8]
64. Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 2009; 250: 112-118 [PMID: 19561475 DOI: 10.1097/ SLA.0b013e3181ad83dc]
65. Alvaro D, Gigliozzi A, Attili AF. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 2000; 33: 333-340 [PMID: 10952254 DOI: 10.1016/S0168-8278(00)80377-3]
66. Møller LN, Stidsen CE, Hartmann B, Holst JJ. Somatostatin receptors. Biochim Biophys Acta 2003; 1616: 1-84 [PMID: 14507421 DOI: 10.1016/S0005-2736(03)00235-9]
67. Heisler S, Srikant CB. Somatostatin-14 and somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3',5'-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells. Endocrinology 1985; 117: 217-225 [PMID: 2861077 DOI: 10.1210/ endo-117-1-217]
68. Jakobs KH, Gehring U, Gaugler B, Pfeuffer T, Schultz G. Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc-variants of S49 lymphoma cells. Eur J Biochem 1983; 130: 605-611 [PMID: 6297910 DOI: 10.1111/j.1432-1033.1983.tb07192.x]
69. Tan CK, Podila PV, Taylor JE, Nagorney DM, Wiseman GA, Gores GJ, LaRusso NF. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology 1995; 108: 1908-1916 [PMID: 7768398 DOI: 10.1016/0016-5085(95)90157-4]
70. Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C. Antitumor effects of somatostatin. Mol Cell Endocrinol 2008; 286: 230-237 [PMID: 18359151 DOI: 10.1016/ j.mce.2008.02.002]
71. Walz G. Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel? Nephrol Dial Transplant 2006; 21: 1752-1757 [PMID: 16705023 DOI: 10.1093/ndt/gfl246]
72. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wüthrich RP. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363: 820-829 [PMID: 20581391 DOI: 10.1056/NEJMoa0907419]
73. Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363: 830-840 [PMID: 20581392 DOI: 10.1056/NEJMoa1003491]
74. Watnick T, Germino GG. mTOR inhibitors in polycystic kidney disease. N Engl J Med 2010; 363: 879-881 [PMID: 20581393 DOI: 10.1056/NEJMe1006925]
75. Renken C, Fischer DC, Kundt G, Gretz N, Haffner D. Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol Dial Transplant 2011; 26: 92-100 [PMID: 20615907 DOI: 10.1093/ndt/ gfq384]
76. Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Sawa N, Katori H, Takemoto F, Hara S, Takaichi K. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2007; 49: 744-752 [PMID: 17533017 DOI: 10.1053/j.ajkd.2007.03.018]
77. Park HC, Kim CW, Ro H, Moon JY, Oh KH, Kim Y, Lee JS, Yin YH, Jae HJ, Chung JW, Ahn C, Hwang YH. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients. J Korean Med Sci 2009; 24: 57-61 [PMID: 19270814 DOI: 10.3346/jkms.2009.24.1.57]
78. Saini S, Mueller PR, Ferrucci JT, Simeone JF, Wittenberg J, Butch RJ. Percutaneous aspiration of hepatic cysts does not provide definitive therapy. AJR Am J Roentgenol 1983; 141: 559-560 [PMID: 6603770 DOI: 10.2214/ajr.141.3.559]
79. Bean WJ, Rodan BA. Hepatic cysts: treatment with alcohol. AJR Am J Roentgenol 1985; 144: 237-241 [PMID: 3880981 DOI: 10.2214/ajr.144.2.237]
80. van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008; 53: 2251-2257 [PMID: 18299984 DOI: 10.1007/s10620-007-0121-x]
81. Kairaluoma MI, Leinonen A, Ståhlberg M, Päivänsalo M, Kiviniemi H, Siniluoto T. Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention. Ann Surg 1989; 210: 208-215 [PMID: 2667475 DOI: 10.1097/00000658-198908000-00012]
82. van Keimpema L, Ruurda JP, Ernst MF, van Geffen HJ, Drenth JP. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg 2008; 12: 477-482 [PMID: 17957434 DOI: 10.1007/s11605-007-0376-8]
83. Garcea G, Rajesh A, Dennison AR. Surgical management of cystic lesions in the liver. ANZ J Surg 2013; 83: E3-E20 [PMID: 22537174 DOI: 10.1111/j.1445-2197.2012.06096.x]
84. van Keimpema L, Drenth JP. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 2011; 253: 419; author reply 420 [PMID: 21173690 DOI: 10.1002/bjs.1800710331]
85. Armitage NC, Blumgart LH. Partial resection and fenestration in the treatment of polycystic liver disease. Br J Surg 1984; 71: 242-244 [PMID: 6697135]
86. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296 [PMID: 15647196 DOI: 10.1136/ gut.2004.046524]
87. Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology 2004; 40: 774-782 [PMID: 15382167]
88. Freeman RB, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006; 12: S128-S136 [PMID: 17123284 DOI: 10.1002/lt.20979]
89. Arrazola L, Moonka D, Gish RG, Everson GT. Model for end-stage liver disease (MELD) exception for polycystic liver disease. Liver Transpl 2006; 12: S110-S111 [PMID: 17123287 DOI: 10.1002/lt.20974]
90. Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns MP. Outcome and quality of life in patients with polycystic liver disease after liver or combined liverkidney transplantation. Liver Transpl 2006; 12: 1268-1277 [PMID: 16741930 DOI: 10.1002/lt.20780]
91. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919-921 [PMID: 7701595]
92. Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, Mayer D, Buckels J, Mirza D, Roskams T, Elias E, Nevens F, Fevery J, McMaster P. Liver transplantation for polycystic liver disease. Liver Transpl 2001; 7: 238-245 [PMID: 11244166 DOI: 10.1053/jlts.2001.22178]
93. Szabó LS, Takács I, Arkosy P, Sápy P, Szentkereszty Z. Laparoscopic treatment of nonparasitic hepatic cysts. Surg Endosc 2006; 20: 595-597 [PMID: 16437277 DOI: 10.1007/ s00464-005-0206-6]
94. Martin IJ, McKinley AJ, Currie EJ, Holmes P, Garden OJ. Tailoring the management of nonparasitic liver cysts. Ann Surg 1998; 228: 167-172 [PMID: 9712560 DOI: 10.1097/000006 58-199808000-00004]
95. Liska V, Treska V, Mírka H, Skalický T, Sutnar A, Ferda J. [Treatment strategy in non-parasitic benign cysts of the liver]. Rozhl Chir 2008; 87: 512-516 [PMID: 19110943]
96. Bai XL, Liang TB, Yu J, Wang WL, Shen Y, Zhang M, Zheng SS. Long-term results of laparoscopic fenestration for patients with congenital liver cysts. Hepatobiliary Pancreat Dis Int 2007; 6: 600-603 [PMID: 18086625]
97. Palanivelu C, Rangarajan M, Senthilkumar R, Madankumar MV. Laparoscopic management of symptomatic multiple hepatic cysts: a combination of deroofing and radical excision. JSLS 2007; 11: 466-469 [PMID: 18237512]
98. Garcea G, Pattenden CJ, Stephenson J, Dennison AR, Berry DP. Nine-year single-center experience with nonparastic liver cysts: diagnosis and management. Dig Dis Sci 2007; 52: 185-191 [PMID: 17160469 DOI: 10.1007/s10620-006-9545-y]
99. Neri V, Ambrosi A, Fersini A, Valentino TP. Laparoscopic treatment of biliary hepatic cysts: short-and medium-term results. HPB (Oxford) 2006; 8: 306-310 [PMID: 18333141 DOI: 10.1080/13651820500465766]
100. Kornprat P, Cerwenka H, Bacher H, El-Shabrawi A, Tillich M, Langner C, Mischinger HJ. Surgical therapy options in polycystic liver disease. Wien Klin Wochenschr 2005; 117: 215-218 [PMID: 15875761 DOI: 10.1007/s00508-005-0309-z]
101. Robinson TN, Stiegmann GV, Everson GT. Laparoscopic palliation of polycystic liver disease. Surg Endosc 2005; 19: 130-132 [PMID: 15531969 DOI: 10.1007/s00464-004-8813-1]
102. Fiamingo P, Tedeschi U, Veroux M, Cillo U, Brolese A, Da Rold A, Madia C, Zanus G, D'Amico DF. Laparoscopic treatment of simple hepatic cysts and polycystic liver disease. Surg Endosc 2003; 17: 623-626 [PMID: 12574922 DOI: 10.1007/ s00464-002-9088-z]
103. Tocchi A, Mazzoni G, Costa G, Cassini D, Bettelli E, Agostini N, Miccini M. Symptomatic nonparasitic hepatic cysts: options for and results of surgical management. Arch Surg 2002; 137: 154-158 [PMID: 11822951 DOI: 10.1001/archsurg. 137.2.154]
104. Koperna T, Vogl S, Satzinger U, Schulz F. Nonparasitic cysts of the liver: results and options of surgical treatment. World J Surg 1997; 21: 850-854; discussion 854-855 [PMID: 9327677 DOI: 10.1007/s002689900316]
105. Morino M, Garrone C, Festa V, Miglietta C. Laparoscopic treatment of non parasitic liver cysts. Ann Chir 1996; 50: 419-425; discussion 426-430 [PMID: 8991197]
106. Farges O, Bismuth H. Fenestration in the management of polycystic liver disease. World J Surg 1995; 19: 25-30 [PMID: 7740806 DOI: 10.1007/BF00316975]
107. Li TJ, Zhang HB, Lu JH, Zhao J, Yang N, Yang GS. Treatment of polycystic liver disease with resection-fenestration and a new classification. World J Gastroenterol 2008; 14: 5066-5072 [PMID: 18763291 DOI: 10.3748/wjg.14.5066]
108. Gamblin TC, Holloway SE, Heckman JT, Geller DA. Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg 2008; 207: 731-736 [PMID: 18954786 DOI: 10.1016/j.jamcollsurg.2008.07.009]
109. Yang GS, Li QG, Lu JH, Yang N, Zhang HB, Zhou XP. Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients. World J Gastroenterol 2004; 10: 2598-2601 [PMID: 15300916]
110. Vons C, Chauveau D, Martinod E, Smadja C, Capron F, Grunfeld JP, Franco D. [Liver resection in patients with polycystic liver disease]. Gastroenterol Clin Biol 1998; 22: 50-54 [PMID: 9762166]
111. Soravia C, Mentha G, Giostra E, Morel P, Rohner A. Surgery for adult polycystic liver disease. Surgery 1995; 117: 272-275 [PMID: 7878532 DOI: 10.1016/S0039-6060(05)80201-6]
112. Henne-Bruns D, Klomp HJ, Kremer B. Non-parasitic liver cysts and polycystic liver disease: results of surgical treatment. Hepatogastroenterology 1993; 40: 1-5 [PMID: 8462920]
113. Vauthey JN, Maddern GJ, Kolbinger P, Baer HU, Blumgart LH. Clinical experience with adult polycystic liver disease. Br J Surg 1992; 79: 562-565 [PMID: 1611453 DOI: 10.1002/ bjs.1800790629]
114. Sanchez H, Gagner M, Rossi RL, Jenkins RL, Lewis WD, Munson JL, Braasch JW. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991; 161: 113-18; discussion 113-18; [PMID: 1987844 DOI: 10.1016/0002-9610(91)90370-S]
115. Newman KD, Torres VE, Rakela J, Nagorney DM. Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure. Ann Surg 1990; 212: 30-37 [PMID: 2363601 DOI: 10.1097/00000658-199007000-00005]
116. Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann Surg 1988; 208: 421-434 [PMID: 3178330 DOI: 10.1097/00000658-198810000-00004]
117. Taner B, Willingham DL, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB. Polycystic liver disease and liver transplantation: single-institution experience. Transplant Proc 2009; 41: 3769-3771 [PMID: 19917384 DOI: 10.1016/j.transproceed.200 9.05.043]
118. Ueno T, Barri YM, Netto GJ, Martin A, Onaca N, Sanchez EQ, Chinnakotla S, Randall HB, Dawson S, Levy MF, Goldstein RM, Klintmalm GB. Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation 2006; 82: 501-507 [PMID: 16926594 DOI: 10.1097/01.tp.0000231712.75645.7a]
119. Ueda M, Egawa H, Oike F, Taira K, Uryuhara K, Fujimoto Y, Kozaki K, Tanaka K. Living-donor liver transplantation for polycystic liver disease. Transplantation 2004; 77: 480-481 [PMID: 14966436 DOI: 10.1097/01.TP.0000110319.60723.31]
120. Gustafsson BI, Friman S, Mjornstedt L, Olausson M, Backman L. Liver transplantation for polycystic liver disease--indications and outcome. Transplant Proc 2003; 35: 813-814 [PMID: 12644149 DOI: 10.1016/S0041-1345(03)00081-2]
121. Swenson K, Seu P, Kinkhabwala M, Maggard M, Martin P, Goss J, Busuttil R. Liver transplantation for adult polycystic liver disease. Hepatology 1998; 28: 412-415 [PMID: 9696005 DOI: 10.1002/hep.510280218]
122. Lang H, von Woellwarth J, Oldhafer KJ, Behrend M, Schlitt HJ, Nashan B, Pichlmayr R. Liver transplantation in patients with polycystic liver disease. Transplant Proc 1997; 29: 2832-2833 [PMID: 9365580 DOI: 10.1016/ S0041-1345(97)00696-9]
123. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Liver transplantation for adult polycystic liver disease. Liver Transpl Surg 1996; 2: 17-22 [PMID: 9346624 DOI: 10.1002/ lt.500020105]
124. Starzl TE, Reyes J, Tzakis A, Mieles L, Todo S, Gordon R. Liver transplantation for polycystic liver disease. Arch Surg 1990; 125: 575-577 [PMID: 2331212 DOI: 10.1001/archsurg. 1990.01410170021003]